Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients

Starting soon

Conditions studied: Chronic Disease, Immunocompromised, HIV Infection, Chronic Kidney Disease, Solid Organ Transplantation, Hematopoietic Stem Cell Transplantation, Cancer, Autoimmune Diseases, Inflammatory Bowel Disease, Asplenia, Frailty

In brief

AMBU-VAX is a prospective, single-center observational study designed to develop and implement an organizational model for delivering recommended vaccinations within a hospital setting. The study targets adult and elderly patients with chronic diseases or immunocompromising conditions who are eligible for vaccination according to national immunization guidelines. Vaccination is actively proposed during outpatient visits, hospital admissions, or at discharge and, when accepted, administered within the hospital or coordinated with local public health vaccination services. The study aims to evaluate the feasibility, uptake, and completion of hospital-based vaccination pathways and to support integration between hospital and territorial prevention services for vulnerable populations.

Key facts

Study ID

NCT07391046

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

1500

Starts

2026-02-01

Expected to finish

2027-02-01

Last updated by the study team

2026-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged ≥18 years
• Presence of at least one chronic or immunocompromising condition eligible for vaccination according to national guidelines
• Written informed consent provided

You may not qualify if…

• Age <18 years
• Conditions not included among the predefined eligibility criteria

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.